rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2009-2-19
|
pubmed:abstractText |
The persistence of minimal residual disease (MRD) following therapy is an established prognostic factor in precursor B-cell acute lymphoblastic leukemia (pB-ALL). Detection of MRD in pB-ALL by flow cytometric immunophenotyping requires demonstration of abnormal antigen expression in leukemic B-cell precursors relative to that of normal B-cell precursors. The gene encoding CD49f (integrin alpha-6) is one of several whose overexpression in pB-ALL at diagnosis has been associated with the subsequent detection of MRD. However, whether CD49f might be a useful reagent in the immunophenotypic detection of MRD in pB-ALL has not been evaluated.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1552-4957
|
pubmed:author |
|
pubmed:copyrightInfo |
2008 Clinical Cytometry Society.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
76
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
150-5
|
pubmed:dateRevised |
2009-12-11
|
pubmed:meshHeading |
pubmed-meshheading:18831072-Adolescent,
pubmed-meshheading:18831072-Age Factors,
pubmed-meshheading:18831072-B-Lymphocytes,
pubmed-meshheading:18831072-Biological Markers,
pubmed-meshheading:18831072-Child,
pubmed-meshheading:18831072-Child, Preschool,
pubmed-meshheading:18831072-Female,
pubmed-meshheading:18831072-Flow Cytometry,
pubmed-meshheading:18831072-Humans,
pubmed-meshheading:18831072-Immunophenotyping,
pubmed-meshheading:18831072-Infant,
pubmed-meshheading:18831072-Integrin alpha6,
pubmed-meshheading:18831072-Male,
pubmed-meshheading:18831072-Neoplasm, Residual,
pubmed-meshheading:18831072-Neoplasm Recurrence, Local,
pubmed-meshheading:18831072-Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:18831072-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:18831072-Precursor Cells, B-Lymphoid,
pubmed-meshheading:18831072-Predictive Value of Tests,
pubmed-meshheading:18831072-Prognosis,
pubmed-meshheading:18831072-Young Adult
|
pubmed:year |
2009
|
pubmed:articleTitle |
Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
|
pubmed:affiliation |
Department of Pathology and Laboratory Medicine, Hartford Hospital, Connecticut 06102-5037, USA. jdigius@harthosp.org
|
pubmed:publicationType |
Journal Article
|